AMPHIVENA RESTORE

WIPO WIPO 2021

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark AMPHIVENA RESTORE was filed as Word mark on 04/23/2021 at the World Intellectual Property Organization.

Trademark Details Last update: October 20, 2022

Trademark form Word mark
File reference 1594450
Countries em United Kingdom
Base trademark US No. , August 24, 2024
Application date April 23, 2021
Expiration date February 14, 2022

Trademark owner

Two Tower Place, Suite 1000
South San Francisco CA 94080
US

Trademark representatives

P.O. Box 1022 Minneapolis MN 55440-1022 US

goods and services

42 Laboratory research in the field of polypeptides, particularly antibodies and antibody derivatives; product development, in the field of medicaments, namely, polypeptides, particularly antibodies and antibody derivatives, for use in the treatment of tumorous diseases, allergies, autoimmunity, inflammation, infectious diseases, osteoporosis, graft versus host disease, transplant rejection, coronary heart diseases and minimal residual diseases; product development, in the field of diagnostic and testing apparatus and instruments for the identification of tumorous diseases, allergies, autoimmunity, inflammation, infectious diseases, osteoporosis, graft versus host diseases, transplant rejection, coronary heart diseases and minimal residual diseases, and for the identification of expressed genes, particularly of abnormal expressed genes, for the analysis and identification of the gene expression pattern and eukaryotic cells, particularly of single cells and cell culture lines, particularly of mammalian and human cells, particularly of cells of microscopic small biopsies of animal and human tissues, of cells out of tissue samples prepared with laser, of cells isolated with FACS or with receptor to ligand binding, of chemical fixed tissue, of micrometastatic cells, of bone marrow cells, of samples of body fluids, particularly from liquor, blood, lymph, urine or bowel movement, of stem cells, cloned single cells or differentiated stages from specific cells
44 Medical services in the field of oncology and engineered biologics and protein

Trademark history

Date Document number Area Entry
September 21, 2022 2022/42 Gaz US RAW: Total Ceasing Effect
October 20, 2021 2021/42 Gaz EM Rejection
October 20, 2021 2021/42 Gaz GB Rejection
April 23, 2021 2021/20 Gaz US Registration

ID: 141594450